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SUMMARY – Hashimoto thyroiditis is characterized by anti-thyroid peroxidase (anti-TPO) and 
anti-thyroglobulin (anti-Tg) antibodies that gradually lead to thyroid cell destruction. As hypothy-
roidism has been associated with insulin resistance (IR), we aimed to investigate whether IR is associ-
ated with thyroid antibody presence and whether the degree of IR correlates with their concentration 
in euthyroid individuals. A total of 164 non-diabetic, euthyroid individuals, average age 34 years, were 
included in the study, divided into two groups according to Hashimoto thyroiditis and underwent 
5-hour oral glucose tolerance test. The degree of IR was evaluated by the Homeostatic Model Assess-
ment of Insulin Resistance (HOMA-IR). The Hashimoto thyroiditis group had higher HOMA-IR 
(p=0.003) and lower glucose levels (p=0.04). HOMA-IR correlated positively with anti-TPO 
(p<0.001). Linear logistic regression revealed that anti-TPO concentration increased by 18.13 
(p=0.001) with each HOMA-IR unit. IR might trigger thyroid antibody production and Hashimoto 
thyroiditis development, which needs to be evaluated in further larger scale follow up studies.
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Introduction
Thyroid disorders are present in a great proportion 
of general population worldwide1, with hypothyroid-
ism that affects up to 10% of adult population as the 
most common one2. Although there is a spectrum of 
pathophysiologic factors that precipitate this condi-
tion, autoimmune hypothyroidism, i.e. Hashimoto 
thyroiditis is the most common one in the areas of ad-
equate iodine intake3. Hashimoto thyroiditis is part of 
the spectrum of autoimmune thyroid diseases and is 
characterized by various cell- and autoantibody-medi-
ated destruction of thyroid cells4. The presence of typi-
cally anti-thyroid peroxidase (anti-TPO) and anti-
thyroglobulin (anti-Tg) antibodies (Abs) delineates 
the cause of hypothyroidism as Hashimoto thyroiditis 
or its variant, although 10%-15% of patients with 
Hashimoto thyroiditis may be antibody negative4,5.
It is well established that hypothyroidism contrib-
utes to insulin resistance (IR)5,6 and related disorders 
including central obesity, dyslipidemia, impaired car-
diac contractility, endothelial dysfunction, atheroscle-
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rosis and increased carotid intima-media thickness7,8. 
In addition, several studies demonstrated overt and 
subclinical hypothyroidism due to Hashimoto to be 
more prevalent in individuals with diabetes mellitus as 
compared with general population9, and women with 
subclinical hypothyroidism are believed to be at a 
higher risk to develop gestational diabetes10. Thyroid 
hormones are known to have a stimulating effect on 
maturation of the insulin secreting beta cells, and thy-
roid hormone receptors have been detected in these 
cells11. They also enhance gluconeogenesis and glyco-
genolysis in an opposing effect to insulin12, while being 
known to facilitate the cellular glucose uptake by ex-
pressing the glucose transporter-4 isozyme13.
Knowing that overt hypothyroidism and even sub-
clinical hypothyroidism have been associated with dis-
orders of glucose and insulin metabolism14 and that 
thyroid replacement therapy is unable to restore insu-
lin mediated glucose uptake15, while IR-index is si-
multaneously showing association with anti-TPO16, 
we hypothesized that IR might contribute to Hashi-
moto disease development. Thus, the primary aim of 
this study was to investigate whether IR is associated 
with thyroid autoantibody presence and whether the 
degree of IR correlates with their concentration in eu-
thyroid individuals.
Subjects and Methods
This cross-sectional study was conducted at Day 
Hospital of the Mladen Sekso Department of Endo-
crinology, Diabetology and Metabolic Diseases, Sestre 
milosrdnice University Hospital Centre in Zagreb, 
Croatia, and included 164 non-diabetic, euthyroid in-
dividuals with clinical signs of IR, i.e. obesity or his-
tory of excessive body weight, history of biochemical 
abnormalities such as dyslipidemia detected during 
routine screening or workup for a cardiovascular dis-
ease, history of hypertension, symptoms of coronary 
artery disease, symptoms related to other macrovascu-
lar disease (e.g., stroke, peripheral vascular disease), 
microvascular angina, young women with obesity and 
features of hyperandrogenism (frontal baldness and 
hirsutism, but rarely features of virilization), women 
with polycystic ovary syndrome, infertile individuals 
without evident endocrine disorder, and individuals 
with the history of hypoglycemia17.
Body weight was measured with light clothing on a 
balance scale and height to the nearest 0.5 cm using a 
meter that was stabilized on the wall. Body mass index 
(BMI) was calculated as weight (kilograms) divided by 
height (square meters). All laboratory tests were per-
formed after a 12-h overnight fast. Biochemical pa-
rameters including glucose and lipid levels (total cho-
lesterol (TC), high-density lipoprotein cholesterol 
(HDL-C) and triglycerides (TG)) and liver enzymes 
(alanine transaminase (ALT), aspartate transaminase 
(AST), high-sensitivity C-reactive protein (hsCRP) 
and creatinine) were evaluated on an Olympus ana-
lyzer (Olympus AU600, Olympus Optical Co., Tokyo, 
Japan). Low-density lipoprotein cholesterol (LDL-C) 
was calculated using Friedewald’s formula18. Each in-
dividual underwent 5-hour oral glucose tolerance test 
(5h-OGTT). They were instructed about adequate 
carbohydrate consumption prior to testing. The test 
was performed after an overnight fast, between 7 AM 
and 8 AM. An intravenous catheter was placed in the 
forearm. After obtaining the baseline blood samples, 
the participants ingested 75 g of glucose at 0 min, and 
additional blood samples were obtained every 30 min 
thereafter for 5 hours.
Insulin resistance was assessed by the homeostasis 
model assessment index (HOMA-IR): fasting glucose 
(mmol/L) × fasting insulin (uIU/mL)/22.5). Thyroid 
stimulating hormone (TSH), triiodothyronine (T3) 
and thyroxin (T4) concentrations were measured by 
immunochemiluminescense assay. Anti-TPO and an-
ti-Tg were determined by radioimmunoassay. The 
threshold for anti-TPO was <34 kIU/L and for anti-
Tg <115 kIU/L.
Diagnosis of hypothyroidism was established if se-
rum TSH concentration was more than 4 mIU/L (ref-
erence range 0.4-4 nmol/L) and serum T4 concentra-
tion less than 58 nmol/L (reference range 58-161 
nmol/L). Individuals with serum TSH level more than 
4 mIU/L accompanied by normal T4 and T3 levels 
were considered as subclinical hypothyroid cases. All 
patients with enlarged rubbery thyroid and positive 
serum anti-TPO and/or anti-Tg antibody concentra-
tion were categorized as Hashimoto thyroiditis.
Patients with diabetes mellitus, overt hypothyroid-
ism, history of thyroid surgery or radioiodine ablation, 
cardiovascular disease, cerebral vascular disease, corti-
costeroid consumption, pregnancy, chronic liver dis-
ease, thyroid cancer, renal dysfunction and any autoim-
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mune disease such as lupus erythematous and rheuma-
toid arthritis were not included in the study. None of 
the study individuals was under medication known to 
affect glucose or lipid metabolism.
The study protocol was approved by the Ethics 
Committee of the Sestre milosrdnice University Hos-
pital Centre, Zagreb, Croatia, and was performed ac-
cording to the Declaration of Helsinki and Good 
Clinical Practice guidelines. A written informed con-
sent was obtained from all study participants prior to 
entering the study.
Statistical analysis was performed by using Statisti-
cal Package for Social Sciences (SPSS) version 23. The 
normality of distribution was accessed by Shapiro-
Wilk test. All variables were log-transformed to cor-
rect for their skewed distribution. Baseline characteris-
tics of the groups were compared using t-test or χ2-
test. Correlations were tested by Pearson’s coefficient 
of correlation. The HOMA-IR was adjusted for the 
possible confounders in linear logistic regression ana-
lyzing its association with TSH, anti-TPO and anti-
Tg, and in binary logistic regression with Hashimoto 
thyroiditis as an independent variable. The level of sta-
tistical significance was set at p<0.05.
Results
A total of 164 non-diabetic, euthyroid individuals, 
average age 34 years, 92.69% (n=152) of females, were 
included in the study. They were divided into two 
groups according to the presence or absence of Has-
himoto thyroiditis. Their anthropometric and labora-
tory characteristics, as well as differences between 
them are shown in Table 1. Briefly, patients with 
Hashimoto thyroiditis were younger, had higher BMI, 
total and LDL cholesterol, as well as triglycerides, 
 fasting and 5h-OGTT insulin concentration and 
HOMA-IR but lower both fasting and 5h-OGTT 
glucose levels. Anti-Tg and anti-TPO were positive 
in 50 (45.05%), anti-Tg in 8 (7.2%) and anti-TPO in 
53 (47.74%) patients. In the Hashimoto group, 73 
(65.77%) patients had HOMA-IR >2.5, significantly 
Table 1. Differences in anthropometric and laboratory findings between euthyroid patients  
with and without Hashimoto disease
Variable Patients without Hashimoto thyroiditis (N=53)
Patients with Hashimoto 
thyroiditis (N=111) p
Age (years) 35.9±1.9 32.3±1.2 0.103
Gender, female, n (%) 3 (5.6) 9(8.1) 0.159
Body mass index (kg/m2) 25.5±3.1 26.0±2.9 0.605
Total serum cholesterol (mmol/L) 4.56±0.71 4.91±0.66 0.124
HDL cholesterol (mmol/L) 1.89±0.56 1.45±0.61 0.213
LDL cholesterol (mmol/L) 3.12±0.64 3.18±0.60 0.841
Triglycerides (mmol/L) 0.98±0.41 1.01±0.33 0.935
Fasting plasma glucose (mmol/L) 4.71±0.55 4.69±0.48 0.452
5h-OGTT glucose (mmol/L) 6.27±0.20 5.11±0.16 0.04
Fasting plasma insulin (mIU/L) 11.41±1.59 13.93±1.79 0.07
5h-OGTT insulin (mIU/L) 52.44±1.4 46.71±1.2 0.004
HOMA-IR 3.21±2.8 4.35±2.1 0.003
TSH (mIU/L) 1.50±0.6 3.20±0.3 <0.001
T3 (nmol/L) 1.30 ± 0.21 1.22± 0. 03 0.09
T4 (nmol/L) 98.87±2.55 101.01±1.19 0.902
Anti-TPO (kIU/L) 5.45±0.95 165.61±4.25 <0.001
Anti-Tg (kIU/L) 85.15±5.78 171.15±2.71 <0.001
HDL = high-density lipoprotein; LDL = low-density lipoprotein; 5h-OGTT = 5-hour oral glucose tolerance test; HOMA-IR 
= Homeostatic Model Assessment of Insulin Resistance; TSH = thyroid-stimulating hormone; T3 = triiodothyronine; 
T4 = thyroxine; anti-TPO = anti-thyroid peroxidase antibodies; anti-Tg = anti-thyroglobulin antibodies
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higher compared to the Hashimoto free group (n=18; 
33.96%; p=0.001).
The 5h-OGTT plasma insulin correlated posi-
tively with TSH (r=0.41, p=0.01) and anti-TPO 
(r=0.61, p<0.001) but negatively with T3 (r=-0.25, 
p=0.05) and T4 (r=-0.24, p=0.05). Similarly, HOMA-
IR correlated positively with TSH (r=0.47, p=0.01) 
and anti-TPO (r=0.58, p<0.001) but negatively with 
T3 (r=-0.25, p=0.05) and T4 (r=-0.31, p=0.02) (Fig. 
1a-d).
Linear logistic regression revealed that with each 1 
mIU/L increase in 5h-OGTT plasma insulin, TSH 
concentration raised by 0.22 nmol/L (0.13-0.31; 
p<0.001) and anti-TPO by 1.56 (1.39-3.28; p=0.018) 
after age, gender and BMI adjustment. In addition, 
with each HOMA-IR unit increase, TSH concentra-
tion raised by 1.16 nmol/L (0.24-2.07; p=0.015) and 
TPO by 18.13 (11.43-28.75; p=0.001), whereas T4 
dropped by 1.44 nmol/L (-2.69-(-0.303; p=0.016). 
Other study variables showed no statistical signifi-
cance (data not shown).
Finally, on binary logistic regression HOMA-IR 
remained an independent predictor of Hashimoto 
thyroiditis with a prevalence of 1.755 (95% CI 1.773-
1.899; p<0.001).
Discussion
Our study results showed a high prevalence of IR 
in euthyroid patients with Hashimoto disease and 
Fig. 1. (a) Correlation between 5-h insulin concentration and TSH; (b) correlation between 5-h insulin concentration 
and anti-TPO; (c) correlation between HOMA-IR and TSH; (d) correlation between HOMA-IR and anti-TPO.
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strong positive correlation between HOMA-IR de-
gree and anti-TPO. In addition, we clearly demon-
strated that 5h-OGTT plasma insulin and HOMA-
IR correlated not only with TSH but also with anti-
TPO, i.e. that an increase in 5h-OGTT plasma insu-
lin, as well as HOMA-IR increased TSH and 
anti-TPO concentrations in otherwise metabolically 
healthy individuals. These results are partially in ac-
cordance with Iacobellis et al.19, who clearly demon-
strated a significant relationship between thyroid 
function and insulin resistance parameters such as M 
index from euglycemic clamp, fasting insulin and 
HOMA-IR index. However, as indicated by these au-
thors, their findings should be interpreted with cau-
tion since they might be influenced by BMI because 
their study included obese women with BMI >40 kg/
m2. The participants in our study did not have BMI 
>30 kg/m2 and thus the weight itself could not influ-
ence the results. Furthermore, it confirms the data that 
IR itself is a multifactorial disease and that it affects 
non-obese individuals20.
In the past decade, there was a tremendous interest 
in elucidating the relationship between thyroid func-
tion and insulin levels. It is established that clinical 
hypothyroidism is considered as an insulin-resistant 
state6,21, however, the causal relationship between these 
two states has not been completely understood. Al-
though it has been reported that hypothyroidism 
makes glucose inaccessible to insulin22, an exact patho-
genetic mechanism involved in IR in hypothyroidism 
remains unknown. Recently, Mazaheri et al.16 tried to 
detect association of autoimmunity against thyroid 
and IR. When adjusted for age and sex, hypothyroid 
patients had a higher rate of central obesity than gen-
eral population. Moreover, the high prevalence of IR 
(44%) in their patients who all were euthyroid for a 
long time before the study, indicated a mechanism 
other than the role of low thyroid hormones for IR in 
hypothyroidism. Higher central fat in their subjects 
might explain the high prevalence of IR among par-
ticipants, however, a significantly higher fasting insulin 
level was detected in a subgroup of patients with 
Hashimoto thyroiditis and highly elevated levels of 
anti-TPO antibodies, which might support the con-
cept of IR role in autoimmunity, which is partially in 
accordance with our study results although we did not 
measure waist circumference as a measure of central 
obesity.
Hashimoto disease could be considered a T helper 
1 disease in which proinflammatory cytokines such as 
tumor necrosis factor alpha (TNF-α) and interleu-
kin-6 (IL-6) play a crucial role23,24. There is a connec-
tion between the level of anti-TPO antibodies and 
proinflammatory cytokines such as TNF-α and IL-6, 
which appear at higher concentrations in individuals 
with IR25. The production of proinflammatory cyto-
kines might result in an immunity complex, which 
then activates the complement pathway and ultimately 
the T cells, thus leading to an increase in antibodies 
produced against the antigens specific to the thyroid 
such as TPO23. Therefore, anti-TPO antibodies, which 
play a predictive role in the progress of hypothyroid-
ism, can have either direct cytotoxic effect on thyroid 
cells through the IgG1 class24, or indirect destructive 
effect on thyrocytes through activating TH1 cells and 
increasing inflammatory response via release of in-
flammatory cytokines26.
Moreover, the present study showed the euthyroid 
subjects positive for anti-TPO and/or anti-Tg anti-
bodies to have higher total serum cholesterol and LDL 
cholesterol but lower serum HDL concentration as 
compared to the antibody negative group, which is also 
partially in accordance with Mazaheri et al.16. Howev-
er, except for the Hashimoto thyroiditis subgroup with 
highly positive antibody levels, they did not find any 
difference between patients with and without autoim-
munity regarding their lipid profile. We could explain 
these differences with the fact that some of their study 
participants were using levothyroxine in therapy, which 
definitely interfered with the results obtained. There is 
a growing body of literature suggesting the effect of 
levothyroxine on lipid profile, suggesting that its ad-
ministration indeed helps reduce total cholesterol and 
LDL to a limited extent27. Tamer et al.28 suggest that 
thyroid autoimmunity disorder correlates with hyper-
lipidemia and atherosclerosis independently of thyroid 
function, which could also be explained in the light of 
our study results, i.e. thyroid autoimmunity might be 
at least partially a consequence of IR, which promotes 
dyslipidemia.
Finally, our study had several limitations that 
should be pointed out, e.g., a relatively limited 
sample size, short follow up and greatly outnumbered 
female to male subjects, which made the results impos-
sible to generalize to male patients with Hashimoto 
thyroiditis.
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In conclusion, despite limitations, we do believe 
that IR triggers thyroid antibody production and 
Hashimoto disease development, and if so, that it 
might even lead to progression to hypothyroidism, 
which needs to be evaluated in further larger scale fol-
low up studies.
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Sažetak
POVEZANOST SUBKLINIČKE INZULINSKE REZISTENCIJE  
S AUTOIMUNIM BILJEZIMA ŠTITNE ŽLIJEZDE U EUTIROIDNIH ISPITANIKA
K. Blaslov, D. Gajski, V. Vucelić, P. Gaćina, G. Mirošević, J. Marinković, M. Vrkljan i K. Rotim
Hashimotov tireoidits obilježavaju anti-TPO i anti-Tg antitijela koja postupno dovode do uništenja stanica štitne žlijez-
de. Kako se hipotireoza povezuje s inzulinskom rezistencijom (IR) cilj ovoga istraživanja bio je ispitati postoji li povezanost 
IR s prisutnošću tireoidnih antitijela te je li stupanj IR povezan s koncentracijom autoantitijela u eutiroidnih ispitanika. U 
istraživanje je bilo uključeno 164 eutiroidnih ispitanika bez šećerne bolesti koji su podijeljeni u dvije skupine ovisno o prisut-
nosti Hashimotova tireoiditisa. Svi ispitanici podvrgnuti su 5-satnom testu opterećenja glukozom. Stupanj IR izračunat je 
standardiziranom metodom HOMA-IR (engl. Homeostatic Model Assessment of Insulin Resistance). Skupina ispitanika s 
 Hashimotovim tireoiditisom imala je više vrijednosti HOMA-IR (p=0,003), ali i nižu koncentraciju glukoze (p=0,04). 
 HOMA-IR pozitivno je korelirao s anti-TPO (p<0,001). Linearna logistička regresija pokazala je da koncentracija anti-
TPO poraste za 18,13 (p=0,001) sa svakom jedinicom porasta HOMA-IR. IR je mogući okidač za razvoj autoantitijela 
štitnjače i razvoj Hashimotove bolesti, što treba evaluirati u budućim prospektivnim istraživanjima.
Ključne riječi: Inzulinska rezistencija; 5-satni OGTT; Hashimotov tireoiditis
